One year after reports of supply chain issues, 49% of reports in the US and 34% of reports in Canada were associated with ...

Increased relative risk for adverse events seen among those admitted during weeks with high versus low COVID-19 burden ...

The FDA has issued a proposal to remove a common decongestant in over the counter products.

Full results from the trial will be presented at an upcoming medical meeting. Topline results from a phase 3 trial show that tezepelumab statistically significantly reduced the size of nasal polyps ...

Credit: Journey Medical Corporation. The approval was supported by data from 2 randomized, double-blind, active- and ...

One year after reports of supply chain issues, 49% of reports in the US and 34% of reports in Canada were associated with drug shortages. Board Chairman Kelly Aberasturi told the AP that while he ...

The Orphan Drug designation was supported by preclinical research and preliminary data from the dose escalation/expansion phase 1/2 trial.

Early-life exposure to nitrogen dioxide, fine particulate matter linked to prevalence and persistence of peanut allergy. Diego J. Lopez, PhD, from the University of Melbourne in Australia, and ...

HealthDay News — The prevalence of diabetes was 15.8% among US adults during August 2021 to August 2023, according to a November data brief published by the National Center for Health Statistics.

Increase in Parkinson disease risk seen in association with exposure to two or more courses of antifungals 1 to 5 years prior. HealthDay News — Adults who have received multiple penicillin ...

The PDUFA target date is August 21, 2025. The Food and Drug Administration (FDA) has accepted the New Drug Application (NDA) for donidalorsen for the prophylactic treatment of hereditary ...

Cranberry products (compared with the control group) and nitrofurantoin (compared with the control, trimethoprim-sulfamethoxazole, or trimethoprim groups) led to lower odds of symptomatic UTI ...